Table 1 Specificity and sensitivity of the developed ELISAs based on sample time collection.

From: SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients

ELISA

Specificity (%)

Sensitivity (%)

Week 1

Week 2

Week 3

Week 4

S1 IgG

97.6

40.0

91.3

100

100

S1 IgM

97.6

20.0

87.0

100

100

N IgG

91.2

60.0

100

100

100

N IgM

94.4

30.0

91.3

78.6

60.0

Back to article page